Amplified and overexpressed expression of SETDB1 generally exists in lung cancer [2,11,12,13,14], while inactivation of SETDB1 was discovered in mesothelioma [15,16,17,18,19], indicating that SETDB1 plays disparate roles in different cancer types. Here, SETDB1 is linked to cancer.